Brain cancer breakthrough? ultrasound device trial aims to boost drug power

NCT ID NCT06496971

Recruiting now Disease control Sponsor: NaviFUS Corporation Source: ClinicalTrials.gov ↗

First seen Apr 12, 2026 · Last updated Apr 19, 2026 · Updated 1 time

Summary

This study is testing if using a focused ultrasound device (NaviFUS System) along with a standard cancer drug (Avastin) works better than the drug alone for adults with recurrent glioblastoma, a very aggressive brain tumor. The ultrasound is meant to help the drug reach the tumor more effectively. The main goal is to see if the combination keeps the cancer from growing for a longer period.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Linkou Chang Gung Memorial Hospital
RECRUITING

Taoyuan District, 33305, Taiwan

Contact Email: •••••@•••••
National Taiwan University Hospital
RECRUITING

Taipei, 10048, Taiwan

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BRAIN TUMOR BRAIN TUMOR, RECURRENT GLIOBLASTOMA GLIOBLASTOMA MULTIFORME GLIOBLASTOMA MULTIFORME, ADULT GLIOMA NEOPLASMS NEOPLASMS, NERVE TISSUE